FLOMOX

Adverse Events

Drug Profile

Learn More

Reference

About Results

Comments

Flomox Adverse Events Reported to the FDA Over Time

How are Flomox adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Flomox, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Flomox is flagged as the suspect drug causing the adverse event.

Most Common Flomox Adverse Events Reported to the FDA

What are the most common Flomox adverse events reported to the FDA?

Pyrexia	42 (3.5%)
Liver Disorder	38 (3.17%)
Rash	28 (2.34%)
Hepatic Function Abnormal	26 (2.17%)
Stevens-johnson Syndrome	22 (1.83%)
Aspartate Aminotransferase Increase...	21 (1.75%)
Alanine Aminotransferase Increased	17 (1.42%)
Malaise	17 (1.42%)
Disseminated Intravascular Coagulat...	16 (1.33%)
Drug Eruption	14 (1.17%)
Interstitial Lung Disease	14 (1.17%)
	Show More
Depressed Level Of Consciousness	13 (1.08%)
Blood Lactate Dehydrogenase Increas...	12 (1%)
Renal Impairment	12 (1%)
Rhabdomyolysis	12 (1%)
Condition Aggravated	11 (.92%)
Convulsion	11 (.92%)
Jaundice	11 (.92%)
Lymphocyte Stimulation Test Positiv...	11 (.92%)
Blister	10 (.83%)
Blood Bilirubin Increased	10 (.83%)
Ill-defined Disorder	10 (.83%)
Renal Disorder	10 (.83%)
Blood Alkaline Phosphatase Increase...	9 (.75%)
Blood Pressure Decreased	9 (.75%)
Circulatory Collapse	9 (.75%)
Epidermolysis	9 (.75%)
Fall	9 (.75%)
Hepatitis	9 (.75%)
Hyperthermia	9 (.75%)
Renal Failure Acute	9 (.75%)
Toxic Epidermal Necrolysis	9 (.75%)
Vomiting	9 (.75%)
Bacterial Infection	8 (.67%)
Dehydration	8 (.67%)
Drug Hypersensitivity	8 (.67%)
Excoriation	8 (.67%)
Gamma-glutamyltransferase Increased	8 (.67%)
Sepsis	8 (.67%)
Anaphylactic Shock	7 (.58%)
Anorexia	7 (.58%)
Bacteraemia	7 (.58%)
Blood Urea Increased	7 (.58%)
Cerebral Infarction	7 (.58%)
Diarrhoea	7 (.58%)
Haemoglobin Decreased	7 (.58%)
Nasopharyngitis	7 (.58%)
Rash Generalised	7 (.58%)
Back Pain	6 (.5%)
Blood Creatinine Increased	6 (.5%)
Burns Second Degree	6 (.5%)
Burns Third Degree	6 (.5%)
C-reactive Protein Increased	6 (.5%)
Dyspnoea	6 (.5%)
Haemorrhage Subcutaneous	6 (.5%)
Hepatitis Acute	6 (.5%)
Nausea	6 (.5%)
Oral Mucosa Erosion	6 (.5%)
Pneumonia	6 (.5%)
Renal Failure	6 (.5%)
Skin Exfoliation	6 (.5%)
Cardiac Failure Congestive	5 (.42%)
Eosinophil Count Increased	5 (.42%)
Generalised Oedema	5 (.42%)
Haematocrit Decreased	5 (.42%)
Loss Of Consciousness	5 (.42%)
Pleural Effusion	5 (.42%)
Prostatitis	5 (.42%)
Urine Output Decreased	5 (.42%)
Vitamin K Deficiency	5 (.42%)
Abnormal Behaviour	4 (.33%)
Agranulocytosis	4 (.33%)
Altered State Of Consciousness	4 (.33%)
Blood Creatine Phosphokinase Increa...	4 (.33%)
Cardio-respiratory Arrest	4 (.33%)
Cholelithiasis	4 (.33%)
Cyanosis	4 (.33%)
Decreased Appetite	4 (.33%)
Eosinophilia	4 (.33%)
Erythema	4 (.33%)
Headache	4 (.33%)
Hepatic Failure	4 (.33%)
Hepatitis Fulminant	4 (.33%)
Ischaemia	4 (.33%)
Lipoma	4 (.33%)
Mucous Membrane Disorder	4 (.33%)
Overdose	4 (.33%)
Pancreatitis Acute	4 (.33%)
Pyelonephritis Acute	4 (.33%)
Red Blood Cell Count Decreased	4 (.33%)
Respiratory Failure	4 (.33%)
Thirst	4 (.33%)
Tubulointerstitial Nephritis	4 (.33%)
Ventricular Tachycardia	4 (.33%)
White Blood Cell Count Decreased	4 (.33%)
White Blood Cell Count Increased	4 (.33%)
Aggression	3 (.25%)
Ascites	3 (.25%)
Chest X-ray Abnormal	3 (.25%)
Cholestasis	3 (.25%)
Generalised Erythema	3 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Flomox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Flomox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Flomox

What are the most common Flomox adverse events reported to the FDA?

Epidermal And Dermal Conditions	122 (10.18%)
Hepatic And Hepatobiliary	113 (9.42%)
Hepatobiliary	62 (5.17%)
Hematology Investigations	55 (4.59%)
Infections - Pathogen Unspecified	53 (4.42%)
Body Temperature Conditions	51 (4.25%)
Renal Disorders	41 (3.42%)
Enzyme	26 (2.17%)
Neurological	26 (2.17%)
Renal And Urinary Tract Investigati...	26 (2.17%)
Respiratory	25 (2.09%)
	Show More
Gastrointestinal Signs	20 (1.67%)
Lower Respiratory Tract Disorders	20 (1.67%)
Muscle	20 (1.67%)
Allergic Conditions	19 (1.58%)
Injuries	18 (1.5%)
Bacterial Infectious	17 (1.42%)
Coagulopathies And Bleeding Diathes...	16 (1.33%)
Appetite And General Nutritional	14 (1.17%)
Decreased And Nonspecific Blood Pre...	14 (1.17%)
Cardiac And Vascular Investigations	13 (1.08%)
Cardiac Arrhythmias	13 (1.08%)
Injuries By Physical Agents	12 (1%)
Electrolyte And Fluid Balance Condi...	11 (.92%)
Seizures	11 (.92%)
Ocular Infections, Irritations And ...	10 (.83%)
Oral Soft Tissue Conditions	10 (.83%)
Urinary Tract Signs	10 (.83%)
Gastrointestinal Inflammatory Condi...	9 (.75%)
Skin And Subcutaneous Tissue Disord...	9 (.75%)
White Blood Cell	9 (.75%)
Central Nervous System Vascular	8 (.67%)
Gastrointestinal Motility And Defec...	8 (.67%)
Musculoskeletal And Connective Tiss...	8 (.67%)
Protein And Chemistry Analyses	8 (.67%)
Skin Vascular Abnormalities	8 (.67%)
Pleural	7 (.58%)
Gallbladder	6 (.5%)
Heart Failures	6 (.5%)
Hematological And Lymphoid Tissue T...	6 (.5%)
Metabolic, Nutritional And Blood Ga...	6 (.5%)
Nephropathies	6 (.5%)
Procedural And Device Related Injur...	6 (.5%)
Viral Infectious	6 (.5%)
Anemias Nonhemolytic And Marrow Dep...	5 (.42%)
Cardiac Disorder Signs	5 (.42%)
Embolism And Thrombosis	5 (.42%)
Male Reproductive Tract Infections ...	5 (.42%)
Medication Errors	5 (.42%)
Peritoneal And Retroperitoneal Cond...	5 (.42%)
Physical Examination Topics	5 (.42%)
Spleen, Lymphatic And Reticulendoth...	5 (.42%)
Vitamin Related	5 (.42%)
Arteriosclerosis, Stenosis, Vascula...	4 (.33%)
Exocrine Pancreas Conditions	4 (.33%)
Headaches	4 (.33%)
Psychiatric And Behavioural Symptom...	4 (.33%)
Soft Tissue Neoplasms Benign	4 (.33%)
Upper Respiratory Tract Disorders	4 (.33%)
Bone And Joint Injuries	3 (.25%)
Glaucoma And Ocular Hypertension	3 (.25%)
Glucose Metabolism Disorders	3 (.25%)
Joint	3 (.25%)
Miscellaneous And Site Unspecified ...	3 (.25%)
Mycoplasmal Infectious	3 (.25%)
Personality Disorders	3 (.25%)
Respiratory And Pulmonary Investiga...	3 (.25%)
Therapeutic And Nontherapeutic Effe...	3 (.25%)
Vascular Hypertensive	3 (.25%)
Administration Site Reactions	2 (.17%)
Angiedema And Urticaria	2 (.17%)
Bronchial Disorders	2 (.17%)
Coronary Artery	2 (.17%)
Encephalopathies	2 (.17%)
Fungal Infectious	2 (.17%)
Gastrointestinal Hemorrhages	2 (.17%)
Gastrointestinal Stenosis And Obstr...	2 (.17%)
Hearing	2 (.17%)
Hematopoietic Neoplasms	2 (.17%)
Immune	2 (.17%)
Immunology And Allergy	2 (.17%)
Inner Ear And Viiith Cranial Nerve	2 (.17%)
Lipid Analyses	2 (.17%)
Movement Disorders	2 (.17%)
Musculoskeletal And Soft Tissue Inv...	2 (.17%)
Myocardial	2 (.17%)
Skin Appendage Conditions	2 (.17%)
Sleep Disorders	2 (.17%)
Suicidal And Self-injurious Behavio...	2 (.17%)
Vascular	2 (.17%)
Vascular Hemorrhagic	2 (.17%)
Water, Electrolyte And Mineral	2 (.17%)
Acid-base	1 (.08%)
Anxiety Disorders	1 (.08%)
Bladder And Bladder Neck Disorders	1 (.08%)
Central Nervous System Infections A...	1 (.08%)
Eye	1 (.08%)
Gastrointestinal	1 (.08%)
Hematological	1 (.08%)
Lipid Metabolism	1 (.08%)
Microbiology And Serology	1 (.08%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Flomox, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Flomox is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Flomox According to Those Reporting Adverse Events

Why are people taking Flomox, according to those reporting adverse events to the FDA?

Infection Prophylaxis	64
Drug Use For Unknown Indication	49
Bronchitis	41
Nasopharyngitis	39
Prophylaxis	33
Upper Respiratory Tract Inflammatio...	27
	Show More
Infection	24
Pyrexia	23
Product Used For Unknown Indication	21
Cystitis	21
Pharyngitis	19
Pneumonia	14
Influenza	13
Cellulitis	11
Inflammation	10
Urinary Tract Infection	10
Excoriation	8
Tooth Extraction	8
Cough	8
Otitis Media	7
Subcutaneous Abscess	6
Respiratory Tract Infection	6
Upper Respiratory Tract Infection	6
Pyoderma	5
Bronchitis Acute	5
Skin Ulcer	5
Hydronephrosis	4
Bacterial Infection	4
Otitis Media Acute	4
Arteriosclerosis	4
Infection Parasitic	4
Systemic Antibacterial Therapy	3
Granuloma	3
Pneumonia Bacterial	3
Tonsillitis	3
Pain	3
Purulence	3
Cataract Operation Complication	3
Lymphadenitis	3
Gingivitis	2
Atherosclerosis	2
Chalazion	2
Systemic Mycosis	2
Periodontitis	2
Biopsy Muscle	2
Postoperative Care	2
Oropharyngeal Pain	2
Chronic Sinusitis	2
Acute Tonsillitis	2
Furuncle	2
Pyelonephritis	2

Flomox Case Reports

What Flomox safety concerns are being reported by doctors and researchers in the medical literature?

About Results

This report contains aggregated drug side effects and adverse events for Flomox. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Flomox.